Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Gathers Research Intelligence For Next Five-Year Plan

This article was originally published in PharmAsia News

Executive Summary

The organizers of 863 Program recently held a strategic seminar on biomedical devices, biochips and nano-biotechnology for China's 12th five-year plan. Experts analyzed the world's development trends of these fields, examined key local academic institutions' research directions, as well as forecast the major requirements and progress of the sector during the five-year plan. Top executives from venture capitalists Morgan Stanley, WI Harper Group and Japan's SoftBank pointed out that China's life sciences research focus is in line with global market trends. They suggested that the next step should emphasize the commercialization of scientific achievements and their clinical applications. (Click here for more - Chinese Language)
UsernamePublicRestriction

Register

SC071893

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel